Trials / Completed
CompletedNCT04976868
Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the present multicentre, prospective, non-interventional study (NIS) is gathering knowledge on the actual use and effectiveness of Elidel® in Chinese patients with mild to moderate AD affecting sensitive skin areas in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pimecrolimus 1% Top Cream | Elidel® as prescribed within routine clinical practice |
Timeline
- Start date
- 2021-03-18
- Primary completion
- 2022-10-31
- Completion
- 2022-10-31
- First posted
- 2021-07-26
- Last updated
- 2023-05-24
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04976868. Inclusion in this directory is not an endorsement.